Article
Beta(1)-selective agonist (-)-1-(3,4-dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] differentially interacts with key amino acids responsible for beta(1)-selective binding in resting and active states.
The Journal of pharmacology and experimental therapeutics - 1 Apr 2002
Sugimoto Yoshiyuki, Fujisawa Reiko, Tanimura Ryuji, Lattion Anne Laure, Cotecchia Susanna, Tsujimoto Gozoh, Nagao Taku, Kurose Hitoshi
Abstract excerpt
(-)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] is a highly selective beta(1)-adrenergic receptor (beta(1)AR) agonist. To study the binding site of beta(1)-selective agonist, chimeric beta(1)/beta(2)ARs and Ala-substituted beta(1)ARs were constructed. Several key residues of beta(1)AR [Leu(110) and Thr(117) in transmembrane domain (TMD) 2], and Phe(359) in TMD 7] were found to be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
